Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 4, 2018

Total Value ($000): $101,754 (100.0% shares, 0.0% debt)

Holdings (11)

— Paratek Pharmaceuticals 33.2%

Value ($000) $33,805 Shares 2,600,410 Est. Cost $34.18 Unrealized —

SNNAQ Sienna Biopharmaceuticals 14.0%

Value ($000) $14,247 Shares 758,610 Est. Cost $21.95 Unrealized -20.4%

— ObsEva 13.3%

Value ($000) $13,490 Shares 1,000,000 Est. Cost $9.76 Unrealized —

— Jounce Therapeutics 11.6%

Value ($000) $11,845 Shares 529,965 Est. Cost $21.99 Unrealized —

— CymaBay Therapeutics 7.0%

Value ($000) $7,164 Shares 551,477 Est. Cost $4.71 Unrealized —

— FibroGen 5.9%

Value ($000) $6,036 Shares 130,646 Est. Cost $27.34 Unrealized —

— Pieris Pharmaceuticals 5.2%

Value ($000) $5,308 Shares 778,230 Est. Cost $1.83 Unrealized —

— ESSA Pharma 4.1%

Value ($000) $4,122 Shares 21,696,969 Est. Cost $0.58 Unrealized —

— Dicerna Pharmaceuticals 2.1%

Value ($000) $2,136 Shares 223,457 Est. Cost $16.47 Unrealized —

— Egalet 1.8%

Value ($000) $1,821 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— Cidara Therapeutics 1.7%

Value ($000) $1,780 Shares 444,965 Est. Cost $10.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Paratek Pharmaceuticals	2,600,410	$33,805	33.2%	$34.18	—	Common Stock	699374302
SNNAQ	Sienna Biopharmaceuticals	758,610	$14,247	14.0%	$21.95	-20.4%	Common Stock	82622H108
—	ObsEva	1,000,000	$13,490	13.3%	$9.76	—	Common Stock	H5861P103
—	Jounce Therapeutics	529,965	$11,845	11.6%	$21.99	—	Common Stock	481116101
—	CymaBay Therapeutics	551,477	$7,164	7.0%	$4.71	—	Common Stock	23257D103
—	FibroGen	130,646	$6,036	5.9%	$27.34	—	Common Stock	31572Q808
—	Pieris Pharmaceuticals	778,230	$5,308	5.2%	$1.83	—	Common Stock	720795103
—	ESSA Pharma	21,696,969	$4,122	4.1%	$0.58	—	Common Stock	29668H104
—	Dicerna Pharmaceuticals	223,457	$2,136	2.1%	$16.47	—	Common Stock	253031108
—	Egalet	2,889,926	$1,821	1.8%	$5.98	—	Common Stock	28226B104
—	Cidara Therapeutics	444,965	$1,780	1.7%	$10.40	—	Common Stock	171757107